Irsogladine
- Generic Name
- Irsogladine
- Drug Type
- Small Molecule
- Chemical Formula
- C9H7Cl2N5
- CAS Number
- 57381-26-7
- Unique Ingredient Identifier
- QBX79NZC1D
- Background
Irsogladine is under investigation in clinical trial NCT02581696 (The Drug-drug Interaction and Safety of Lafutidine and Irsogladine Maleate in Healthy Adult Volunteers).
- Indication
⑴用于治疗胃溃疡；⑵用于改善急性胃炎和慢性胃炎急性发作期的胃粘膜病变（糜烂、出血、充血、水肿）。
Therapeutic Effect of Isogladine Maleate on Small Intestinal Mucosal Injury Associated With NSAIDS in Population
Phase 4
- Conditions
- NSAIDs-associated Intestinal Mucosal Injury
- Interventions
- First Posted Date
- 2022-02-22
- Last Posted Date
- 2022-04-04
- Lead Sponsor
- Lee's Pharmaceutical Limited
- Target Recruit Count
- 100
- Registration Number
- NCT05249725
[KJ-INT-002] BE Study
Phase 1
- Conditions
- Gastritis
- Interventions
- Drug: INT-2150
- First Posted Date
- 2018-04-26
- Last Posted Date
- 2018-04-26
- Lead Sponsor
- Kukje Pharma
- Target Recruit Count
- 37
- Registration Number
- NCT03509831
- Locations
- 🇰🇷
Kukje Pharm, Seongnam-si, Korea, Republic of
A Study to Compare the Pharmacokinetics of Lafutidine and Irsogladine Maleate Tablet
Phase 1
Completed
- Conditions
- Gastric Ulcer
- Interventions
- First Posted Date
- 2016-05-03
- Last Posted Date
- 2017-02-07
- Lead Sponsor
- Boryung Pharmaceutical Co., Ltd
- Target Recruit Count
- 34
- Registration Number
- NCT02759224
- Locations
- 🇰🇷
The Catholic University of Korea, Seoul St.Mary's Hospital, Seoul, Korea, Republic of
The Drug-drug Interaction and Safety of Lafutidine and Irsogladine Maleate in Healthy Adult Volunteers
- First Posted Date
- 2015-10-21
- Last Posted Date
- 2017-02-06
- Lead Sponsor
- Boryung Pharmaceutical Co., Ltd
- Target Recruit Count
- 24
- Registration Number
- NCT02581696
- Locations
- 🇰🇷
The Catholic University of Korea, Seoul St.Mary's Hospital, Seoul, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath